1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. FGFR
  4. FGFR Inhibitors

FGFR Inhibitors

FGFR

FGFR1

FGFR2

FGFR3

FGFR4

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

FGFR Inhibitors
Product Name FGFR FGFR1 FGFR2 FGFR3 FGFR4 Purity
Lenvatinib  
FGFR1, IC50: 46 nM
      99.87%
Nintedanib  
FGFR1, IC50: 69 nM
FGFR2, IC50: 37 nM
FGFR3, IC50: 108 nM
  99.97%
Ponatinib  
FGFR1, IC50: 2.2 nM
      99.13%
Erdafitinib  
FGFR1, IC50: 1.2 nM
FGFR2, IC50: 2.5 nM
FGFR3, IC50: 3.0 nM
FGFR4, IC50: 5.7 nM
99.66%
Infigratinib  
FGFR1, IC50: 0.9 nM
FGFR2, IC50: 1.4 nM
FGFR3, IC50: 1 nM
FGFR4, IC50: 60 nM
99.55%
PF 477736      
FGFR3, IC50: 23 nM
  99.21%
FGFR4-IN-1        
FGFR4, IC50: 0.7 nM
99.88%
(Z)-Orantinib  
FGFR1, IC50: 1.2 μM
      99.02%
AZD4547  
FGFR1, IC50: 0.2 nM
FGFR2, IC50: 2.5 nM
FGFR3, IC50: 1.8 nM
FGFR4, IC50: 165 nM
99.68%
Pemigatinib  
FGFR1, IC50: 0.4 nM
FGFR2, IC50: 0.5 nM
FGFR3, IC50: 1.2 nM
FGFR4, IC50: 30 nM
99.88%
SU 5402  
FGFR1, IC50: 30 nM
      99.39%
Fisogatinib        
FGFR4, IC50: 5 nM
99.84%
PD173074  
FGFR1, IC50: 25 nM
      99.67%
Nintedanib esylate  
FGFR1, IC50: 69 nM
FGFR2, IC50: 37 nM
FGFR3, IC50: 108 nM
  99.93%
Futibatinib  
FGFR1, IC50: 3.9 nM
FGFR2, IC50: 1.3 nM
wild-type FGFR2, IC50: 0.3 nM
FGFR2 V5651, IC50: 1-3 nM
FGFR2 N550H, IC50: 3.6 nM
FGFR2 E566G, IC50: 2.4 nM
FGFR3, IC50: 1.6 nM
FGFR4, IC50: 8.3 nM
98.80%
Rogaratinib  
FGFR1
FGFR2
FGFR3
FGFR4
99.86%
Dovitinib  
FGFR1, IC50: 8 nM
 
FGFR3, IC50: 9 nM
  97.18%
Gandotinib    
FGFR2, IC50: 32 nM
FGFR3, IC50: 106 nM
  99.96%
Lucitanib  
FGFR1, IC50: 17.5 nM
FGFR2, IC50: 82.5 nM
    99.32%
LY2874455  
FGFR1, IC50: 2.8 nM
FGFR2, IC50: 2.6 nM
FGFR3, IC50: 6.4 nM
FGFR4, IC50: 6 nM
98.06%
Roblitinib        
FGFR4, IC50: 1.9 nM
99.33%
BLU9931  
FGFR1, IC50: 591 nM
FGFR2, IC50: 493 nM
FGFR3, IC50: 150 nM
FGFR4, IC50: 3 nM
99.95%
KW-2449  
FGFR1, IC50: 36 nM
      99.85%
Pazopanib Hydrochloride  
FGFR1, IC50: 140 nM
      99.83%
PD-166866  
FGFR1, IC50: 52.4 nM
      99.97%
PRN1371  
FGFR1, IC50: 0.6 nM
FGFR2, IC50: 1.3 nM
FGFR3, IC50: 4.1 nM
FGFR4, IC50: 19.3 nM
99.72%
Alofanib    
FGFR2
    99.83%
CH5183284  
FGFR1, IC50: 9.3 nM
FGFR2, IC50: 7.6 nM
FGFR3, IC50: 22 nM
FGFR4, IC50: 290 nM
99.73%
Ferulic acid  
FGFR1, IC50: 3.78 μM
FGFR2, IC50: 12.5 μM
    99.87%
CP-547632
FGFR, IC50: 9 nM
        >99.0%
Sulfatinib  
FGFR1
      98.01%
Lenvatinib mesylate  
FGFR1, IC50: 46 nM
      99.86%
Dovitinib lactate  
FGFR1, IC50: 8 nM
 
FGFR3, IC50: 9 nM
  99.96%
ENMD-2076  
FGFR1, IC50: 92.7 nM
FGFR2, IC50: 70.8 nM
    99.12%
TG 100801  
FGFR1, IC50: 2 nM
FGFR2, IC50: 16 nM
    98.60%
Derazantinib  
FGFR1, IC50: 4.5 nM
FGFR2, IC50: 1.8 nM
FGFR3, IC50: 4.5 nM
  99.18%
Orantinib  
FGFR1, Ki: 1.2 μM
      98.80%
FIIN-2  
FGFR1, IC50: 3.1 nM
FGFR2, IC50: 4.3 nM
FGFR3, IC50: 27 nM
FGFR4, IC50: 45 nM
99.95%
S49076  
FGFR1, IC50: 18 nM
FGFR1V561M, IC50: 23 nM
FGFR2, IC50: 17 nM
FGFR2N549H, IC50: 19 nM
FGFR3, IC50: 15 nM
  98.62%
CP-547632 hydrochloride
FGFR, IC50: 9 nM
        98.24%
ODM-203  
FGFR1, IC50: 11 nM
FGFR2, IC50: 16 nM
FGFR3, IC50: 6 nM
FGFR4, IC50: 35 nM
99.33%
R1530  
FGFR1, IC50: 28 nM
      99.06%
ENMD-2076 Tartrate  
FGFR1, IC50: 92.7 nM
FGFR2, IC50: 70.8 nM
    98.59%
EOC317  
FGFR1, IC50: 6 nM
      98.11%
SSR128129E  
FGFR1, IC50: 1.9 μM
      99.86%
ASP5878  
FGFR1, IC50: 0.47 nM
FGFR2, IC50: 0.6 nM
FGFR3, IC50: 0.74 nM
FGFR4, IC50: 3.5 nM
99.71%
FIIN-3  
FGFR1, IC50: 13.1 nM
FGFR2, IC50: 21 nM
FGFR3, IC50: 31.4 nM
FGFR4, IC50: 35.3 nM
98.13%
Tyrosine kinase-IN-1  
FGFR1, IC50: 2 nM
      99.47%
Infigratinib phosphate  
FGFR1, IC50: 0.9 nM
FGFR2, IC50: 1.4 nM
FGFR3, IC50: 1 nM
FGFR4, IC50: 60 nM
97.74%
FGFR1/DDR2 inhibitor 1  
FGFR1, IC50: 31.1 nM
      99.03%
CPL304110  
FGFR1, IC50: 0.75 nM
FGFR2, IC50: 0.5 nM
FGFR3, IC50: 3.05 nM
 
PD-089828  
FGFR1, IC50: 0.15 μM
FGFR1, Ki: 0.14 μM
     
CP-547632 TFA
FGFR, IC50: 9 nM
        99.42%
PD-161570  
FGFR1, IC50: 39.9 nM
FGFR1, Ki: 42 nM
FGFR1 autophosphorylation, IC50: 622 nM